WallStreetZenWallStreetZen

NASDAQ: TARS
Tarsus Pharmaceuticals Inc Stock Ownership - Who owns Tarsus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tarsus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William J. Phd LinkDirector2026-09-1511,675$78.33
$914.50kSell
William J. Phd LinkDirector2026-09-1566$80.01
$5.28kSell
William J. Phd LinkDirector2026-09-15759$79.00
$59.96kSell
Elizabeth Yeu LinMed2026-09-045,386$90.00
$484.74kSell
Seshadri NeervannanCOO2026-09-044,564$85.00
$387.94kSell
Bobak R. AzamianCEO;Chair;Pres2026-09-047,100$90.27
$640.92kSell
Elizabeth Yeu LinMed2026-09-041,590$90.00
$143.10kSell
Bobak R. AzamianCEO;Chair;Pres2026-09-042,900$91.27
$264.68kSell
Elizabeth Yeu LinMed2026-09-041,590$85.00
$135.15kSell
Elizabeth Yeu LinMed2026-09-045,387$85.00
$457.90kSell

1 of 6

TARS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARS insiders and whales buy or sell their stock.

TARS Shareholders

What type of owners hold Tarsus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital IX LLC13.02%5,714,036$418.95MInsider
Rtw Investments LP4.59%2,013,601$147.64MInsider
Horowitz Limited Partnership VIII4.53%1,987,105$145.69MInsider
Jason E. Tester4.44%1,949,331$142.92MInsider
Frazier Life Sciences IX LP4.37%1,917,157$140.57MInsider
Bobak R. Azamian3.90%1,709,403$125.33MInsider
Michael Ackermann2.98%1,308,273$95.92MInsider
William J. Phd Link0.22%94,487$6.93MInsider
Seshadri Neervannan0.18%79,482$5.83MInsider
Bryan Wahl0.15%63,959$4.69MInsider

1 of 3

TARS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARS0.11%39.11%Net SellingNet Selling
AMLX0.10%50.21%Net SellingNet Selling
IRON0.11%65.28%Net SellingNet Selling
DNLI0.10%57.28%Net SellingNet Selling
ELVN0.11%81.00%Net SellingNet Buying
View Top Biotech Stocks

Tarsus Pharmaceuticals Stock Ownership FAQ

Who owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals (NASDAQ: TARS) is owned by 0.11% institutional shareholders, 39.11% Tarsus Pharmaceuticals insiders, and 60.78% retail investors. Vivo Capital IX LLC is the largest individual Tarsus Pharmaceuticals shareholder, owning 5.71M shares representing 13.02% of the company. Vivo Capital IX LLC's Tarsus Pharmaceuticals shares are currently valued at $415.07M.

If you're new to stock investing, here's how to buy Tarsus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.